EUVIMEDEUVIMED entdecken
Crossref

Short Synthesis of Dopamine Agonist Rotigotine

Srivari Chandrasekhar, Chandra Shekhar, Santanu Karmakar, Prathama S. Mainkar

Synthesis · 16.07.2024 · 56 (14) · 2234-2238

DOI: 10.1055/a-2235-5080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Synthesis, erschienen am 16.07.2024. Verfasst von Srivari Chandrasekhar und 3 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, University Grants Commission, Science and Engineering Research Board.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A practical and short synthesis of FDA approved drug, Rotigotine, is achieved in two steps from 5-methoxy-2-tetralone, which in turn was synthesised by [4+2] cycloaddition of the in situ generated methoxyaryne from its precursor aryl triflate with benzyloxybutadiene or from 4-methoxyindanone via ring expansion using trimethylsilyldiazomethane.

Förderung

  • Council of Scientific and Industrial Research
  • University Grants Commission
  • Science and Engineering Research Board

Zitieren

APA

Chandrasekhar, S., Shekhar, C., Karmakar, S., & Mainkar, P. S. (2024). Short Synthesis of Dopamine Agonist Rotigotine. Synthesis, 56(14), 2234-2238. https://doi.org/10.1055/a-2235-5080

Vancouver

Chandrasekhar S, Shekhar C, Karmakar S, Mainkar PS. Short Synthesis of Dopamine Agonist Rotigotine. Synthesis. 2024;56(14):2234-2238. doi:10.1055/a-2235-5080

BibTeX
@article{Chandrasekhar2024,
  author = {Chandrasekhar, Srivari and Shekhar, Chandra and Karmakar, Santanu and Mainkar, Prathama S.},
  title = {Short Synthesis of Dopamine Agonist Rotigotine},
  journal = {Synthesis},
  year = {2024},
  volume = {56},
  number = {14},
  pages = {2234--2238},
  doi = {10.1055/a-2235-5080}
}
Kostenlos starten →